E for L Aim PCL
SET:EFORL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.4), the stock would be worth ฿0.21 (58% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.9 | ฿0.13 |
0%
|
| 3-Year Average | 1.4 | ฿0.21 |
+58%
|
| 5-Year Average | 2 | ฿0.3 |
+127%
|
| Industry Average | 1.8 | ฿0.27 |
+105%
|
| Country Average | 1 | ฿0.15 |
+13%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
E
|
E for L Aim PCL
SET:EFORL
|
519.8m THB | 0.9 | 11.7 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.9B USD | -78.5 | 23.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 31.5 | 36.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.4B USD | 31.1 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.2B USD | -16.4 | 28.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 6.6 | 35.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.9B CNY | 0.8 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 2.8 | 22.6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
59.8B CNY | 2.5 | 21.1 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 6 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
61B HKD | 0.6 | 7.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 0.7 |
| Median | 1 |
| 70th Percentile | 1.6 |
| Max | 30.3 |
Other Multiples
E for L Aim PCL
Glance View
E for L Aim Public Co., Ltd. is a distributor of medical devices and equipment, and provides advertising services. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2009-02-19. The firm operates in two segments: Distributor of medical devices and equipment and Beauty treatments. The company imports, distributes, and provides services for scientific and medical equipment, and health products. Its medical products include Anesthesia Machine & Monitoring, Infant Incubator, Infant Warmer, Phototherapy, Ultrasound, Electrocardiograph System(ECG), Electroencephalograph(EEG), Intelligent Ventilation, MRI Infusion Pump, Telemonitoring System, and Aerochamber. Its laboratory products include ADVIA 120, ADVIA AutoSlide, CLINITEK Advantus, Urine Strip, Dimension RxL Max, Advia Centaur CP, and Immulite 2000XPI. The company provides microscope for life sciences, such as educational microscopes, clinical & laboratory microscopes, and microscopes for high-end biological scientific research. Its subsidiaries include Spacemed Company Limited and Siam Snail Company Limited.
